Oncolytics Up 1.5% in U.S. Pre-market as Funds Pelareorep's Ongoing Clinical Development
In This Article:
Oncolytics Biotech (ONC.TO, ONCY), a clinical-stage company specializing in immunotherapy for oncolo
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.